Professor Ian Phillips to Speak at Two National Conferences
February 27, 2012
Dr. Ian Phillips, Norris Professor of Life Sciences and Director of the Center for Rare Disease Therapies, is set to speak at two upcoming conferences this March: the Rare Disease Leader's Forum, in San Francisco and the Stem Cells for Drug Developers conference in Boston.

New Team Masters Projects Include Emphasis on Rare Diseases
November 22, 2011
While this year's Team Masters Projects (TMPs) at KGI cover a wide spectrum of topics, four TMPs focus specifically on rare diseases, reflecting an increasing interest among pharmaceutical companies in exploring new business models for developing medicines to treat rare conditions—also known as "orphan drugs."

Professor Ian Phillips to lead Rare Disease Workshop in Boston
November 10, 2011
Professor Ian Phillips will lead a workshop on developing rare disease therapies at the 2nd World Orphan Drug Summit on November 15 in Boston, Massachusetts.

Workshop Leads to New Orphan Drug Opportunities
August 15, 2011
Thanks to a workshop co-sponsored by KGI's Center of Rare Disease Therapies, NATCO Pharma Ltd has become the first Indian company to receive approval from the U.S. Food and Drug Administration (FDA) for an Orphan Drug designation application.

Prof. Phillips to Address Rare Disease Summit
July 7, 2011
Professor Ian Phillips, PhD, director of KGI's Center for Rare Disease Therapies, will talk about the unique role that academics can play in rare disease therapies at the 6th annual Rare Disease Leadership Summit in Washington, DC, July 12-13.

Former FDA Official Tim Coté Joins KGI Faculty
June 15, 2011
Dr. Tim Coté, a former high-level official with the U.S. Food and Drug Administration (FDA), will join Keck Graduate Institute's faculty in July, bringing extensive knowledge and experience in clinical regulatory affairs.

Students Aid Search for Lymphomatic Malformation Cure
May 14, 2011
Three KGI premed students turned a classroom assignment into a successful effort that could eventually help save the lives of hundreds of small children suffering from lymphomatic malformation.

President Schuster Joins National Rare Disease Advocacy Board
March 31, 2011
KGI President Sheldon M. Schuster, PhD, has been elected to the National Organization for Rare Disorders (NORD) Board of Directors, joining other noted leaders in the rare disease community.

KGI to Celebrate Rare Disease Day with Orphan Drug Workshop
January 28, 2011
Keck Graduate Institute (KGI) will celebrate Rare Disease Day on Feb. 28 by hosting its second annual workshop with the U.S. Food and Drug Administration (FDA) for pharmaceutical and biotech companies and academics to learn how to write and file an Orphan Drug designation application.

Rare Disease Center Awarded $100,000
November 15, 2010
KGI's Center for Rare Disease Therapies has received a $100,000 grant from the Kenneth T. and Eileen L. Norris Foundation to continue its mission of encouraging the development of more drug therapies for patients with rare diseases.